“Advantages of Using Liposome-Encapsulated Antibiotics to Fight Infections Caused by Enterobacteria”. Research, Society and Development, vol. 10, no. 6, May 2021, p. e15010615439, https://doi.org/10.33448/rsd-v10i6.15439.